116 related articles for article (PubMed ID: 5558041)
21. LATS-protector activity in thyrotoxicosis measured by thyroidal intracellular colloid droplet formation.
Shishiba Y; Miyachi Y; Takaishi M; Ozawa Y
J Clin Endocrinol Metab; 1978 May; 46(5):841-8. PubMed ID: 262769
[TBL] [Abstract][Full Text] [Related]
22. LATS protector and abnormal thyroid stimulation in diffuse toxic goitre.
Stewart RD
N Z Med J; 1975 Jan; 81(531):24. PubMed ID: 1055311
[No Abstract] [Full Text] [Related]
23. [Anti-thyroid antibodies and thyroglobulin in the serum of patients with hyperthyroidism treated with methylthiouracil].
Junik R; Lacka K; Sowiński J; Horst-Sikorska W; Gembicki M
Pol Tyg Lek; 1987 Sep; 42(36):1120-3. PubMed ID: 3422846
[No Abstract] [Full Text] [Related]
24. The long-acting thyroid stimulator.
Munro DS
Sci Basis Med Annu Rev; 1970; ():21-30. PubMed ID: 4920180
[No Abstract] [Full Text] [Related]
25. The long-acting thyroid stimulator.
Munro DS
J R Coll Physicians Lond; 1972 Apr; 6(3):309-15. PubMed ID: 5066947
[No Abstract] [Full Text] [Related]
26. Proceedings: Studies on long-acting thyroid stimulator protector in serum containing long-acting thyroid stimulator.
Dirmikis S; Munro DS
J Endocrinol; 1975 Mar; 64(3):29P-30P. PubMed ID: 1173370
[No Abstract] [Full Text] [Related]
27. ["Long-acting thyroid stimulator" (LATS) and conventional thyroid antibodies. Comparative studies].
Depisch D; Höfer R; Schatz H
Wien Z Inn Med; 1968; 49(11):418-22. PubMed ID: 5737591
[No Abstract] [Full Text] [Related]
28. Relationship between the long-acting thyroid stimulator and circulating thyroid antibodies in Graves' disease.
Pinchera A; Liberti P; De Santis R; Grasso L; Martino E; Baschieri L
J Clin Endocrinol Metab; 1967 Dec; 27(12):1758-60. PubMed ID: 6072765
[No Abstract] [Full Text] [Related]
29. LATS and thyroid autoantibodies.
Beall GN; Solomon DH
Clin Exp Immunol; 1968 Sep; 3(7):615-9. PubMed ID: 4883066
[TBL] [Abstract][Full Text] [Related]
30. [TSH-receptor-bound antithyroid antibody and the etiology of Basedow's disease].
Shishiba Y
Nihon Rinsho; 1983; 41(4):801-7. PubMed ID: 6310180
[No Abstract] [Full Text] [Related]
31. Hyperthyroidism in Tasmania following iodide supplementation: measurements of thyroid-stimulating autoantibodies and thyrotropin.
Adams DD; Kennedy TH; Stewart JC; Utiger RD; Vidor GI
J Clin Endocrinol Metab; 1975 Aug; 41(2):221-8. PubMed ID: 51028
[TBL] [Abstract][Full Text] [Related]
32. Specific and nonspecific responses in the bioassay of long-acting thyroid stimulator (LATS).
Chopra IJ; Solomon DH; Limberg NP
J Clin Endocrinol Metab; 1970 Oct; 31(4):382-90. PubMed ID: 5468701
[No Abstract] [Full Text] [Related]
33. [Significance of thyroid gland stimulating factors (LATS and LATS-protector) for the disease course of hyperthyroidism].
Wuttke H
Verh Dtsch Ges Inn Med; 1975; 81():1552-4. PubMed ID: 1227022
[No Abstract] [Full Text] [Related]
34. [Immunological mechanisms in thyrotoxicosis].
Bradistilov S
Vutr Boles; 1979; 18(2):9-16. PubMed ID: 380170
[No Abstract] [Full Text] [Related]
35. Long-acting thyroid stimulator (LATS) in hyperthyroidism and exophthalmos.
Friis T
Dan Med Bull; 1969 Nov; 16(10):294-304. PubMed ID: 5392781
[No Abstract] [Full Text] [Related]
36. Long-acting thyroid stimulator protector assay as a basis for identification of subgroups of Graves' ophthalmopathy.
Solomon DH; Chopra IJ; Chopra U; Smith F
Trans Assoc Am Physicians; 1976; 89():159-70. PubMed ID: 828344
[No Abstract] [Full Text] [Related]
37. Failure to detect long-acting thyroid stimulator with the immunofluorescence technique.
Fedder G; Feltkamp TE
Clin Exp Immunol; 1970 Jan; 6(1):167-8. PubMed ID: 4906525
[No Abstract] [Full Text] [Related]
38. [Immunopathogenic reactions of the thyroid gland and their importance for diagnosis].
Uthgenannt H
Internist (Berl); 1969 Aug; 10(8):321-2. PubMed ID: 4904082
[No Abstract] [Full Text] [Related]
39. Evidence that mouse thyroid stimulator does not stimulate the human thyroid gland.
Adams DD; Kennedy TH; Stewart RD
Aust N Z J Med; 1976 Aug; 6(4):300-4. PubMed ID: 1070985
[TBL] [Abstract][Full Text] [Related]
40. A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease.
McKenzie JM; Zakarija M
J Clin Endocrinol Metab; 1976 Apr; 42(4):778-81. PubMed ID: 177449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
